Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02473926 · ClinicalTrials.gov registry record · NA
Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02473926: Completed NA study, sponsored by University of Colorado, Denver.
NCT02473926 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02473926, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study plans to learn more about physical activity and physical function in sedentary older adults with type 2 diabetes.
Primary Outcome
ActiGraph accelerometer measures physical activity objectively as steps/week. These data are presented as the change from baseline values.
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Physical Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-07-29 |
| Phase | NA |
What the finished NCT02473926 record still lists
NCT02473926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT02473926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02473926 about?
NCT02473926 is a clinical study titled "Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes". This study plans to learn more about physical activity and physical function in sedentary older adults with type 2 diabetes.
What is the current status of trial NCT02473926?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-12. Estimated completion is 2019-07-29.
What interventions are being tested in trial NCT02473926?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Physical Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02473926?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02473926's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia